Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Preclinical and Limited Clinical Evidence for Spirulina in Ulcerative Colitis: A Systematic Review and Meta-analysis.

  • 2025-08-18
  • Advanced pharmaceutical bulletin 15(4)
    • Khadije Gorgi
    • Zahra Ghanbarzadegan
    • Amir Darkhosh
    • Sara Shojaei-Zarghani
    • Seyed Vahid Hosseini

Study Design

Type
Review
Population
animal (mammalian) models or patients with UC
Methods
systematic search in PubMed, Scopus, Web of Science, and Embase for studies from 1980 to April 2024; included experimental studies (animal or human) on spirulina for UC; pooled effect sizes with MD or SMD

Purpose

Ulcerative colitis (UC) is a chronic inflammatory disease of the gastrointestinal tract. This study aimed to systematically review available animal and clinical studies on the effects of spirulina (Arthrospira platensis), a natural anti-inflammatory and antioxidant agent, on the condition of UC.

Methods

We conducted a systematic search in the PubMed, Scopus, Web of Science, and Embase databases for studies published from 1980 to April 2024. Experimental studies involving animal (mammalian) models or patients with UC were included. Pooled effect sizes were reported as mean differences (MD) or standardized mean differences (SMD) and 95% confidence intervals (CIs).

Results

A total of 1,321 documents were identified through the systematic search. Following screening, 16 animal studies and 3 randomized controlled trials (RCTs), derived from one trial, were included. The beneficial effects of spirulina on body weight (MD=8.61, 95% CI=2.98 to 14.25, I2: 99.78%), clinical features (SMD=-2.39, 95% CI=-2.95 to -1.83, I2: 5.89%), colon length (MD=1.25, 95% CI=0.59 to 1.91, I2: 95.80%), oxidative stress, inflammatory markers, and gut microbiota in animal models of UC were reported. However, no effect of spirulina on disease activity was reported in the only RCT conducted. Nonetheless, improvements in quality of life, oxidative stress, sleep disturbances, stress scores, and anemia were noted.

Conclusion

Available animal studies suggest beneficial effects of spirulina on UC; however, the limited number of RCTs precludes definitive conclusions.

Research Insights

  • Seaweed→Improved Quality of Life

    improvements in quality of life, oxidative stress, sleep disturbances, stress scores, and anemia were noted

    Effect
    Beneficial
    Effect size
    Small
  • Seaweed→Improved Sleep Disturbance

    improvements in quality of life, oxidative stress, sleep disturbances, stress scores, and anemia were noted

    Effect
    Beneficial
    Effect size
    Small
  • Seaweed→Reduced Anemia

    improvements in quality of life, oxidative stress, sleep disturbances, stress scores, and anemia were noted

    Effect
    Beneficial
    Effect size
    Small
  • Seaweed→Reduced Disease Activity

    no effect of spirulina on disease activity was reported in the only RCT conducted

    Effect
    Neutral
    Effect size
    Small
  • Seaweed→Reduced Oxidative Stress

    improvements in quality of life, oxidative stress, sleep disturbances, stress scores, and anemia were noted

    Effect
    Beneficial
    Effect size
    Small
  • Seaweed→Reduced Stress Scores

    improvements in quality of life, oxidative stress, sleep disturbances, stress scores, and anemia were noted

    Effect
    Beneficial
    Effect size
    Small
Back to top